These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16083874)

  • 61. Protective effects of phosphatidylcholine against mechanisms of ischemia and reperfusion-induced arrhythmias in isolated guinea pig ventricular tissues.
    Duan JM; Moffat MP
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):342-8. PubMed ID: 2280801
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Effects of combined use of dofetilide and verapamil on the action potential of papillary muscles in guinea pigs].
    Li ML; Zeng XR; Yang Y; Du JR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):834-8. PubMed ID: 19950594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of the antiarrhythmic drug dofetilide on transmural dispersion of repolarization in ventriculum. A computer modeling study.
    Saiz J; Gomis-Tena J; Monserrat M; Ferrero JM; Cardona K; Chorro J
    IEEE Trans Biomed Eng; 2011 Jan; 58(1):43-53. PubMed ID: 20851784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
    Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
    J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action.
    Curtis MJ; Barsby RW; Forster R
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):643-51. PubMed ID: 7596134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database.
    Pratt CM; Al-Khalidi HR; Brum JM; Holroyde MJ; Schwartz PJ; Marcello SR; Borggrefe M; Dorian P; Camm AJ;
    J Am Coll Cardiol; 2006 Aug; 48(3):471-7. PubMed ID: 16875971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion.
    Pasnani JS; Ferrier GR
    J Pharmacol Exp Ther; 1994 Oct; 271(1):184-92. PubMed ID: 7965713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential.
    Gao Z; Milnes JT; Choisy SC; Leach MJ; Hancox JC; James AF
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1088-96. PubMed ID: 16445575
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dronedarone versus amiodarone in preventing premature ventricular contractions in an in vitro model of "border zone".
    Alexandre J; Rouet R; Puddu PE; Beygui F; Manrique A; Milliez P
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):49-57. PubMed ID: 24084222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Frequency-independent blockade of cardiac Na+ channels by riluzole: comparison with established anticonvulsants and class I anti-arrhythmics.
    Mestre M; Djellas Y; Carriot T; Cavero I
    Fundam Clin Pharmacol; 2000; 14(2):107-17. PubMed ID: 10796057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Arrhythmia and delayed recovery of cardiac action potential during reperfusion after ischemia. Role of oxygen radical-induced no-reflow phenomenon.
    Aiello EA; Jabr RI; Cole WC
    Circ Res; 1995 Jul; 77(1):153-62. PubMed ID: 7788873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs.
    Wirth KJ; Uhde J; Rosenstein B; Englert HC; Gögelein H; Schölkens BA; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):155-60. PubMed ID: 10685870
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Azimilide. NE 10064, Stedicor.
    Drugs R D; 1999 Apr; 1(4):297-300. PubMed ID: 10566048
    [No Abstract]   [Full Text] [Related]  

  • 75. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
    Drexler AP; Micklas JM; Brooks RR
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of the I(K.ATP) blockers glibenclamide and HMR1883 on cardiac electrophysiology during ischemia and reperfusion.
    Dhein S; Pejman P; Krüsemann K
    Eur J Pharmacol; 2000 Jun; 398(2):273-84. PubMed ID: 10854840
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Azimilide dihydrochloride: a new class III anti-arrhythmic agent.
    Abrol R; Page RL
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2705-15. PubMed ID: 11060832
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibitory effect of azimilide on Na+/Ca2+ exchange current in guinea-pig cardiac myocytes.
    Watanabe Y; Kimura J
    J Pharmacol Sci; 2010; 114(1):111-4. PubMed ID: 20710119
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
    Ferreira AJ; Santos RA; Almeida AP
    Hypertension; 2001 Sep; 38(3 Pt 2):665-8. PubMed ID: 11566952
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide.
    Grover GJ; D'Alonzo AJ; Dzwonczyk S; Parham CS; Darbenzio RB
    Am J Physiol; 1996 Sep; 271(3 Pt 2):H1207-14. PubMed ID: 8853361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.